| 1 |
33608672 | Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin. | 2021 Nov |
2 |
| 2 |
34873318 | Author Correction: Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin. | 2021 Dec 6 |
1 |
| 3 |
19760159 | Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations. | 2010 Dec |
2 |
| 4 |
16156861 | Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells. | 2005 Sep |
1 |
| 5 |
11879577 | Morphologic change and elevation of cortisol secretion in cultured human normal adrenocortical cells caused by mutant p21K-ras protein. | 2002 Jan |
1 |
| 6 |
12434292 | Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway. | 2002 Oct 21 |
1 |
| 7 |
9472115 | Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis. | 1998 Mar |
1 |
| 8 |
8672984 | Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. | 1995 Oct-Nov |
1 |